Endo International Financial Statements (ENDP)

Endo Internationalsmart-lab.ru %   2021Q2 2021Q3 2021Q4 2022Q1 2022Q2   LTM ?
Report date 06.08.2021 05.11.2021 01.03.2022 06.05.2022 09.08.2022   09.08.2022
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 713.8 772.0 789.4 652.3 569.1   2 783
Operating Income, bln rub 183.1 213.5 -404.1 61.3 -1 734   -1 863
EBITDA, bln rub ? 256.5 180.1 -297.4 167.6 -1 881   -1 831
Net profit, bln rub ? -15.5 -77.2 -556.7 -65.3 -1 885   -2 585
OCF, bln rub ? 155.0 62.1 -49.9 201.3   213.6
CAPEX, bln rub ? 27.1 25.2 8.95 47.5   81.6
FCF, bln rub ? 127.9 36.9 -58.8 153.8   131.9
Dividend payout, bln rub 0.000 0.000 0.000 0.000   0.000
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 0.00% 0.00% 0.00% 0.00% 0.00%   0
OPEX, bln rub 212.3 272.5 308.6 263.3 210.6   1 055
Cost of production, bln rub 318.5 286.1 311.2 273.2 263.8   1 134
R&D, bln rub 34.7 25.6 58.5 36.1 29.8   150.1
Interest expenses, bln rub 141.6 143.0 143.5 135.1 139.8   561.4
Assets, bln rub 9 206 9 247 8 767 8 447 6 362   6 362
Net Assets, bln rub ? -617.0 -690.3 -1 244 -1 311 -2 899   -2 899
Debt, bln rub 8 321 8 320 8 082 8 110 8 105   8 105
Cash, bln rub 1 545 1 569 1 507 1 413 1 192   1 192
Net debt, bln rub 6 776 6 752 6 575 6 697 6 914   6 914
Ordinary share price, rub 4.68 3.24 3.76 2.31 0.466   0.100
Number of ordinary shares, mln 233.3 233.6 233.7 233.9 235.1   235.1
Market cap, bln rub 1 092 757 879 540 109   24
EV, bln rub ? 7 868 7 509 7 453 7 237 7 023   6 937
Book value, bln rub -6 726 -6 705 -6 804 -6 761 -6 481   -6 481
EPS, rub ? -0.07 -0.33 -2.38 -0.28 -8.02   -11.0
FCF/share, rub 0.55 0.16 -0.25 0.66 0.00   0.56
BV/share, rub -28.8 -28.7 -29.1 -28.9 -27.6   -27.6
EBITDA margin, % ? 35.9% 23.3% -37.7% 25.7% -330.5%   -65.8%
Net margin, % ? -2.17% -10.0% -70.5% -10.0% -331.3%   -92.9%
FCF yield, % ? -27.4% -22.1% 37.9% 48.1% 120.5%   561.0%
ROE, % ? -11.3% -9.87% 48.9% 54.5% 89.2%   89.2%
ROA, % ? 0.75% 0.74% -6.93% -8.46% -40.6%   -40.6%
P/E ? 15.7 11.1 -1.45 -0.76 -0.04   -0.01
P/FCF -3.64 -4.53 2.64 2.08 0.83   0.18
P/S ? 0.39 0.26 0.29 0.18 0.04   0.01
P/BV ? -0.16 -0.11 -0.13 -0.08 -0.02   0.00
EV/EBITDA ? 8.06 7.78 17.2 23.6 -3.84   -3.79
Debt/EBITDA 6.94 7.00 15.1 21.8 -3.78   -3.78
R&D/CAPEX, % 127.9% 101.8% 654.3% 76.0%   183.8%
CAPEX/Revenue, % 3.80% 3.26% 1.13% 7.29% 0.00%   2.93%
Endo International shareholders